Best of Show Award Winners Named at 2011 Bio-IT World Conference & Expo

Share Article

Products from OpenEye, NextDocs, Denodo, and Microway recognized for their innovation across the life sciences research, discovery, and clinical trials process.

CHI's Bio-IT World Conference & Expo announced the products that won the Best of Show Awards at a ceremony held on Wednesday, April 13th at the World Trade Center Boston during the Bio-IT World Conference & Expo. The winning products include; Denodo Technologies' Platform 4.7, Microway's BioStack-LS™, NextDocs Clinical Document Management Solutions, and Open Eye's FastROCS.

Judged by a team of Bio-IT World magazine editors and highly regarded industry experts, the Best of Show Awards recognize new products that demonstrate exceptional technology innovations across the life sciences research, discovery and clinical trials process.

Thirteen finalists were chosen, amongst four categories, and the following winners were selected from the finalists. The winners were judged based on the products' technical merit, functionality and innovation, and in-person presentations to the judges at the show.

  •     Informatics Tools & Data

OpenEye Scientific's FastROCS

  •     IT Hardware Infrastructure

Microway's BioStack-LS™

  •     Web-Based Services Software

Denodo Technologies Platform 4.7

  •     Clinical Trials & Research

NextDocs Clinical Document Management Solutions

Best of Show Award Winners:

Denodo Platform announced their new version 4.7 that advances the integration with Enterprise Ecosystems and the Cloud. It delivers relevant information to business users when they need it, while increasing flexibility and time to information and for less cost. Data Virtualization abstracts data from disparate sources and integrates them virtually into Business Views.

The Microway BioStack-LS™ is a modular, extensible cluster for life science researchers. With 84 cores and 14 GPUs it provides dense compute power that's easy to use. With over 15 TFLOPS of InfiniBand-connected computing power spread over 6272 GPU and 84 x86 CPU cores, the BioStack-LS provides vastly superior performance to traditional compute clusters. To ensure ease of use it is equipped with Bright Computing advanced cluster management tools for node monitoring, rapid deployment of new nodes, and full GPU integration and management.

NextDocs is the leading provider of Microsoft SharePoint-based Document and Quality Management solutions to the life sciences industries. NextDocs Clinical offers clients their choice of implementing our solutions using either SharePoint 2007 or SharePoint 2010 - Microsoft's award-winning web-based collaboration platform. NextDocs extends SharePoint's robust feature set to address the rigorous regulatory requirements that govern global biopharmaceutical organizations.

Open Eye's FastROCS is the resultant application that achieves the goal of dramatically improving the "time to answer" of 3D shape similarity searches. FastROCS facilitates a complete redesign of the traditional virtual screening workflow. Virtual screening is typically run in batches on in-­‐house Linux clusters. This approach required dedicated molecular modeler time or extensive in-­‐house customization. FastROCS runs so fast it is not bound by the traditional Linux cluster batch processing system. FastROCS runs on a single GPU compute server as a web service that any modeler or chemist can query. Used in this manner, FastROCS provides bona fide 3D modeling results on the same time scale as a simple cheminformatics database query.

ABOUT BIO-IT WORLD CONFERENCE & EXPO
Since its debut in 2002, the annual Bio-IT World Conference & Expo (http://www.bio-itworldexpo.com) has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The Conference attracts a highly influential audience consisting of senior level scientists, IT professionals and Executives from organizations across the life sciences industry including Pharmaceutical, Biotechnology, Health Systems, Academia, Government and National Laboratories. In 2010, over 1,700 delegates gathered to share information and discuss enabling technologies that are driving the drug discovery process. The event features concurrent tracks with 100+ technology and scientific presentations.

ABOUT CAMBRIDGE HEALTHTECH INSTITUTE
Founded in 1992, Cambridge Healthtech Institute (CHI) (http://www.healthtech.com) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.

For more information, contact:             
Demetrios Louloudes
Marketing Manager    
Cambridge Healthtech Institute
dlouloudes (at) healthtech (dot) com

Press Contact:
Tracy Fielding
Cambridge Healthtech Institute
Ph. (781) 972- 5429
tfielding (at) healthtech (dot) com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tracey Fielding

978-580-6526
Email >